摘要: An approval by the US Food and Drug Administration later this month for Protalix/Pfizer's plant-derived human therapeutic protein taliglucerase alfa would mark a first 'pharmers'.
nature.com
sci-hub.se 参考文章(0)
摘要: An approval by the US Food and Drug Administration later this month for Protalix/Pfizer's plant-derived human therapeutic protein taliglucerase alfa would mark a first 'pharmers'.